CervoMed (CRVO) Tax Provisions (2014 - 2021)

CervoMed (CRVO) posted Tax Provisions of -$400000.0 for Q4 2021, up 9.89% sequentially from -$443893.0 in Q3 2021.

CervoMed (CRVO) Tax Provisions (2014 - 2021) Analysis & Trends

CervoMed has reported Tax Provisions for 6 years, with the latest figure at -$400000.0 in Q4 2021.

Quarterly Tax Provisions changed N/A year-over-year to -$400000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2022 was -$843893.0 (changed 0.0% YoY) and the FY2021 annual result came in at -$400000.0, up 76.12% from the prior year.
Tax Provisions grew to -$400000.0 in Q4 2021 per CRVO's latest filing, from -$443893.0 in the prior quarter.
Over five years, Tax Provisions peaked at $818101.0 in Q4 2019 and troughed at -$805676.0 in Q3 2020.
A 4-year average of -$218639.8 and a median of -$246946.0 in 2018 frame the typical range for Tax Provisions.
The sharpest annual moves came in 2019 and 2020: Tax Provisions soared 1712.52% in 2019, then plunged 365.85% in 2020.
Over 4 years, Tax Provisions stood at $45136.0 in 2018, then jumped by 1712.52% to $818101.0 in 2019, then sank by 198.48% to -$805676.0 in 2020, then soared by 50.35% to -$400000.0 in 2021.
According to Business Quant data, Tax Provisions over the past three periods registered -$400000.0, -$443893.0, and -$805676.0 for Q4 2021, Q3 2021, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	CervoMed	26.64 Mn	26.64 Mn	-	-

Download Data